News & Events

All the latest news and events from PhoreMost

PhoreMost strengthens leadership team with two key appointments
3rd February 2020

PhoreMost strengthens leadership team with two key appointments

Dr Catherine Beech, OBE, joins Board as a Non-Executive Director Dr Benedict Cross joins as Senior Director [Technology] PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has made two appointments to strengthen its leadership team, as the Company positions itself for growth. Dr Catherine Beech joins the PhoreMost Boa …

PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration
25th June 2019

PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration

PhoreMost and Ligand Subsidiary Vernalis Limited Announce Drug Discovery Collaboration for Novel Oncology Target
12th June 2019

PhoreMost and Ligand Subsidiary Vernalis Limited Announce Drug Discovery Collaboration for Novel Oncology Target

PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs
21st June 2018

PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs

PhoreMost completes $15M (£11M) Series-A round to enter drug discovery
15th May 2018

PhoreMost completes $15M (£11M) Series-A round to enter drug discovery

PhoreMost and NeoPhore Receive Innovate UK Funding to Support Development of a Novel Small-Molecule Cancer Immunotherapy Programme
27th April 2018

PhoreMost and NeoPhore Receive Innovate UK Funding to Support Development of a Novel Small-Molecule Cancer Immunotherapy Programme

PhoreMost and Plexxikon collaborate to identify novel drug targets
16th April 2018

PhoreMost and Plexxikon collaborate to identify novel drug targets

No events currently available